SHFA

⚡ Flash Summary

SHFA announced: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Reg. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SHFA made announcement: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SHFA. Manual verification required.

⚡ Flash Summary

SHFA announced: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Reg. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SHFA made announcement: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SHFA. Manual verification required.

⚡ Flash Summary

SHFA announced: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Reg. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SHFA made announcement: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SHFA. Manual verification required.

⚡ Flash Summary

SHFA announced: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Reg. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SHFA made announcement: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SHFA. Manual verification required.

⚡ Flash Summary

SHFA announced: Board Meeting. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SHFA made announcement: Board Meeting
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SHFA. Manual verification required.

⚡ Flash Summary

On October 6, 2025, Mr. Rashid Javed, a senior management member of Shifa International Hospitals Ltd., purchased 100 shares of the company at a rate of 527.50 per share. The shares were bought through the Central Depository Company (CDC) in the ready market. This transaction increased Mr. Javed’s cumulative shareholding to 3,700 shares, representing 0.01% of the company. The disclosure was made to the Pakistan Stock Exchange as per regulations.

📌 Key Takeaways

• 👨‍💼 Insider Transaction: Mr. Rashid Javed, a senior management member, bought shares.
• 🗓️ Transaction Date: The purchase occurred on October 6, 2025.
• 💰 Purchase Price: Shares were acquired at a rate of PKR 527.50 per share.
• 📈 Number of Shares: 100 shares were purchased.
• 🏦 Depository: The transaction was facilitated through the Central Depository Company (CDC).
• 📊 Market Type: The shares were bought in the ready market.
• ⬆️ Increased Holdings: The purchase increased Mr. Javed’s total holdings to 3,700 shares.
• Ownership Percentage: The cumulative shareholding represents 0.01% of the company.
• 📜 Regulatory Compliance: The disclosure was made in compliance with PSX regulations 5.6.4.
• 🏥 Company: Shifa International Hospitals Ltd. is the entity involved.

🎯 Investment Thesis

Based solely on this insider transaction, a HOLD recommendation is appropriate. While the purchase indicates some confidence from management, the small size of the transaction does not warrant a change in investment strategy. Further financial analysis and market trends should be considered before making a BUY or SELL decision.

⚡ Flash Summary

SHFA announced: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Reg. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SHFA made announcement: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SHFA. Manual verification required.

⚡ Flash Summary

SHFA announced: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Reg. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SHFA made announcement: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SHFA. Manual verification required.

⚡ Flash Summary

Shifa International Hospitals Ltd. is holding its 39th Annual General Meeting (AGM) on October 25, 2025, to approve the audited financial statements for the year ended June 30, 2025. The meeting will also cover the approval of a final cash dividend of 50% (Rs. 5 per share). Shareholders can participate in the AGM through video-link by registering in advance. The share transfer books will be closed from October 17, 2025, to October 25, 2025.

📌 Key Takeaways

• 🗓️ The 39th Annual General Meeting (AGM) will be held on Saturday, October 25, 2025, at 11:00 hours.
• 🏢 The AGM will take place at the Company’s registered office and can be attended via video-link.
• ✅ Shareholders need to register by October 23, 2025, to participate via video-link.
• 📑 The meeting will confirm the minutes of the Extraordinary General Meeting held on June 05, 2025.
• 🧾 Audited financial statements for the year ended June 30, 2025, will be considered and adopted.
• 💰 A final cash dividend of 50% (Rs. 5 per share of Rs. 10 each) will be considered for approval.
• auditors for the year ending June 30, 2026, will be appointed.
• 🛑 Share transfer books will be closed from October 17, 2025, to October 25, 2025.
• proxy must be appointed 48 hours before the meeting.
• 🏦 Shareholders must provide their International Bank Account Number (IBAN) to receive cash dividends.
• 💳 CNIC numbers are mandatory for dividend payment.
• taxes on cash dividend for filers is 15% and 30% for non-filers.
• 🚫 Companies are prohibited from giving gifts to shareholders during the AGM.
• 🌐 The Annual Audited Financial Statements/Annual Report can be found at https://www.shifa.com.pk/annual-report/.

🎯 Investment Thesis

HOLD. This announcement mainly covers the procedural aspects of the AGM and dividend distribution. More comprehensive financial analysis is necessary before making a firm investment decision. A price target cannot be determined without detailed financial data.